Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Dietary supplement GMP development should be higher CFSAN priority, CRN says.

This article was originally published in The Tan Sheet

Executive Summary

SUPPLEMENT GMP DEVELOPMENT HIGHER PRIORITY AT CFSAN URGED BY CRN Director of Scientific and Regulatory Affairs Annette Dickinson, PhD, at a Center for Food Safety & Applied Nutrition meeting in Washington, D.C. June 25. CFSAN called the public meeting to discuss its agenda and set priorities in light of Section 406 of the FDA Modernization Act that requires FDA to publish a plan for complying with its statutory obligations on the one-year anniversary of enactment of the law.
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS088583

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel